During a median follow-up of 5.4 (IQR 5.15.9) years, patients with a 1.5 mg/week subcutaneous injection of dulaglutide showed a lower incidence rate of the primary composite outcome including non-fatal myocardial infarction, non-fatal stroke, or death from cardiovascular causes ( HR = 0.88, 95% CI 0.790.99, P = 0.026) [62]
(5.9) Adverse Reactions/Side Effects Most common adverse reactions (incidence 5%) are nausea, abdominal pain, diarrhea, decreased appetite, vomiting and constipation
If you wanted 2.5mg/mL, you'd add 4mL
Conclusion While it is understandable to want to increase your Ozempic dose after two weeks, doing so goes against clinical safety guidelines and increases the risk of severe side effects
That thing is cement hard
Semaglutide is a compounded medication and is not associated with the Novo Nordisk company or the brand-name medications Wegovy or Ozempic